Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

(TEVA)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Teva Pharmaceutical Industries : , three U.S. drug distributors reach opioid settlement - source

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/21/2019 | 08:42am EST
The logo of Teva Pharmaceutical Industries is seen during a news conference in Tel Aviv

(Reuters) - Drug maker Teva Pharmaceutical Industries Inc and the three biggest U.S. drug distributors reached a settlement on Monday to avoid a trial over their role in the opioid addiction crisis, a source said on Monday.

Distributors Mckesson Corp, Cardinal Health Inc and AmerisourceBergen Corp were set to go to trial Monday morning, along with pharmacy chain Walgreen Boots Alliance Inc.

The source did not say if Walgreen was part of the settlement.

(Reporting by Tom Hals in Wilmington, Delaware; editing by Jason Neely)

Stocks mentioned in the article
ChangeLast1st jan.
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 0.75% 3363 Delayed Quote.-44.04%
WALGREENS BOOTS ALLIANCE 0.76% 62.72 Delayed Quote.-8.21%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on TEVA PHARMACEUTICAL INDUST
11/11TEVA PHARMACEUTICAL INDUSTRIES : Announces Launch of $1,500,000,000 Offering of ..
AQ
11/11TEVA PHARMACEUTICAL INDUSTRIES : Announces $1.5 Billion Debt Tender Offers
AQ
11/08TEVA PHARMACEUTICAL INDUSTRIES : Announces $1.5 Billion Debt Tender Offers
BU
11/08TEVA PHARMACEUTICAL INDUSTRIES : Announces Launch of $1,500,000,000 Offering of ..
BU
11/07TEVA PHARMACEUTICAL INDUSTRIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCI..
AQ
11/07TEVA PHARMACEUTICAL INDUSTRIES : High Debt, Potential Litigation Costs Face New ..
DJ
11/07TEVA PHARMACEUTICAL INDUSTRIES : Pharm says opioid settlement will not derail ab..
RE
11/07Teva Pharmaceutical Names Eli Kalif Chief Financial Officer
DJ
11/07TEVA PHARMACEUTICAL INDUSTRIES : and Celltrion Announce the Availability of TRUX..
BU
11/07TEVA PHARMACEUTICAL INDUSTRIES LTD : Change in Directors or Principal Officers, ..
AQ
More news
Financials (USD)
Sales 2019 17 174 M
EBIT 2019 4 017 M
Net income 2019 -107 M
Debt 2019 25 619 M
Yield 2019 -
P/E ratio 2019 -100,0x
P/E ratio 2020 5,55x
EV / Sales2019 2,01x
EV / Sales2020 1,87x
Capitalization 8 844 M
Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Duration : Period :
Teva Pharmaceutical Industries Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 28
Average target price 9,18  $
Last Close Price 8,10  $
Spread / Highest target 172%
Spread / Average Target 13,4%
Spread / Lowest Target -25,9%
EPS Revisions
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-44.04%8 844
JOHNSON & JOHNSON2.27%344 670
ROCHE HOLDING AG22.47%254 722
MERCK AND COMPANY10.09%211 953
PFIZER-15.30%208 023
NOVARTIS19.53%198 320